Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(21):1639; doi:10.1093/jnci/djh308
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Atkins, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atkins, C. D.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

Re: Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates

Carl D. Atkins

Correspondence to: Carl D. Atkins, MD, South Shore Hematology–Oncology Associates, 242 Merrick Rd., Ste. 301, Rockville Centre, NY 11570-5254 (e-mail: c3atkins@optonline.net)

The first 10% of the full text of this article appears below.

The new American Joint Committee on Cancer (AJCC) staging system for breast cancer correctly recognizes that small clusters of malignant cells do not confer the same adverse prognostic impact as larger metastatic deposits (1). The AJCC’s decision to place . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates
David R. McCready
J Natl Cancer Inst 2004 96: 1639-1640. [Extract] [Full Text] [PDF]